Effect of spironolactone on cardiacsympathetic nerve activity and left ventricular remodeling in patients with dilated cardiomyopathy
- 1 February 2003
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 41 (4), 574-581
- https://doi.org/10.1016/s0735-1097(02)02855-3
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Inverse relationship between aldosterone and large artery compliance in chronically treated heart failure patients.Published by Oxford University Press (OUP) ,1998
- Mineralocorticoid Blockade Reduces Vascular Injury in Stroke-Prone Hypertensive RatsHypertension, 1998
- Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patientsCardiovascular Research, 1997
- Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery diseaseThe American Journal of Cardiology, 1995
- Chronic administration of aldosterone depresses baroreceptor reflex function in the dog.Hypertension, 1994
- Aldosterone and antialdosterone therapy in congestive heart failureThe American Journal of Cardiology, 1993
- Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.Circulation, 1990
- Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.Circulation, 1988
- Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure.Circulation, 1981